[Inhibition of enzymes by an antipsoriatic substance].
D000818:Animals; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000494:pharmacology*; D004988:Ethers, Cyclic / Q000494:pharmacology*; D005634:Fructose-Bisphosphate Aldolase / Q000032:analysis; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D006168:Guinea Pigs; D007770:L-Lactate Dehydrogenase / Q000037:antagonists & inhibitors; D007931:Leucyl Aminopeptidase / Q000037:antagonists & inhibitors; D008297:Male; D011565:Psoriasis / Q000188:drug therapy; D012867:Skin / Q000201:enzymology*; D000637:Transaminases / Q000037:antagonists & inhibitors
D000891:Anti-Infective Agents, Local; D004988:Ethers, Cyclic; D007770:L-Lactate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D000637:Transaminases; D007931:Leucyl Aminopeptidase; D005634:Fructose-Bisphosphate Aldolase
Enzymhemmungen durch eine antipsoriatisch wirksame Substanz.